awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57154768-8882E26D-BCD3-409F-B973-3871B1BFBEA3
Q57154768-8882E26D-BCD3-409F-B973-3871B1BFBEA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57154768-8882E26D-BCD3-409F-B973-3871B1BFBEA3
Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development
P2860
Q57154768-8882E26D-BCD3-409F-B973-3871B1BFBEA3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57154768-8882E26D-BCD3-409F-B973-3871B1BFBEA3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
320b5719cccbcf2171b1a6142444c2fbdaef1b33
P2860
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.